JANX JANUX THERAPEUTICS INC Earnings Reports 8-K Filing 2023 - Results of Operations and Financial Condition Janux Therapeutics, Inc. expects its cash, cash equivalents, restricted cash, and short-term investments to be approximately $304.1 million as of June 30, 2023.Get access to all SEC 8-K filings of the JANUX THERAPEUTICS INC